BackOvid Therapeutics Overview

Ovid Therapeutics Total Liabilities

Latest total liabilities for OVID: $27M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$27.36M
22.26% YoYΔ $4.98M vs prior year quarter

Peer average

Loading

Ovid Therapeutics Total Liabilities History

Loading

Ovid Therapeutics vs. peers: Total Liabilities Comparison

Loading

Ovid Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ovid Therapeutics (OVID) FAQ

As of the most recent data (March 2026), OVID shows a total liabilities of $27M. That compares with $22M in the prior-year period — up 22.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OVID's total liabilities is now $27M (was $22M) — a 22.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Ovid Therapeutics is outperforming or lagging.

Tracking OVID's total liabilities over time shows whether Ovid Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $27M That compares with $22M in the prior-year period — up 22.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Ovid Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $27M) with ownership activity and broader fundamentals.

Ovid Therapeutics's total liabilities is $27M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.